Tianjin, China – July 28, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a leader and pioneer of invasive fungal disease diagnostic field since 199...
YY/T 1729-2020 “Fungus (1-3)-β-D-Glucan Test” formulated by Era Biology was approved by NMPA on July 9, 2020 and officially released. The standard will be formally implemented on June 1...
Tianjin, China – April 21, 2022 – Tianjin Era Biology Technology Co., Ltd is please to announce that Era Biology obtained registration certificates for all seven Carbapenem-resistant Detection K-Se...
The 29th edition of Expomed Eurasia took place on March 17-19, 2022 in Istanbul, Turkey. With 600+ exhibitors from Turkey and around world & 19000 visitors only from Turkey and 5000 intern...
Era Biology has launched a new product series which is Chemiluminescence Immunoassay (CLIA) detection kit for detecting inflammation and bacterial infections. The kit is run on Full-Automatic Chemi...
Meeting Era Biology at ECCMID 2023
The ECCMID congress, the Annual Congress of Clinical Microbiology and Infectious Diseases, is one of the most important events in the field of clinical microbiolo...